social phobia. Fear of scrutiny by other people leading to avoidance of social situations. More pervasive social phobias are usually associated with low self-esteem and fear of criticism. They may present as a complaint of blushing, hand tremor, nausea, or urgency of mi
Conditions
Interventions
Intervention 1: The medication group were treated with Sertraline for 12 weeks. Sertraline was started at a dose of 50 mg and was added to it 50 mg per week until reached into maximum dose of 200 mg
Treatment - Drugs
Behavior
The medication group were treated with Sertraline for 12 weeks. Sertraline was started at a dose of 50 mg and was added to it 50 mg per week until reached into maximum dose of 200 mg over 4 weeks. Tr
Waiting list group did not receive treatment for eight weeks and were evaluated only 4 times.
Psychodynamic psychotherapy intervention group received 21 sessions (in addition to the primary and final evaluations and termination). Individual psychotherapy sessions were held twice per week, each
Sponsors
Tehran University of Medical Science
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having social phobia criteria based on the SCID; SPIN score greater than or equal to 24; age between 18 to 50 years; Exclusion criteria: psychotic disorders; obsessive - compulsive disorder; bipolar disorder; organic brain injury; addiction to drugs and alcohol; impaired impulse control; Cluster A and B personality disorders; disorder on Axis III; history of attempt and suicidal ideation; history of violent behavior; psychotherapy for social phobia over the last 6 months; If there are any other psychotic disorders (except stated in the first clause), primary complaint is not symptoms of social phobia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of symptoms of social phobia- clinician rating. Timepoint: The psychotherapy Group at weeks 1, 8, 15, 23 and the medication group at weeks 1, 4, 8, 12, and the waiting list group at weeks1, 4, 6, 8. Method of measurement: clinical global impression - severity.;Severity of symptoms of social phobia- Patient rating. Timepoint: The psychotherapy Group at weeks 1, 8, 15, 23 and the medication group at weeks 1, 4, 8, 12, and the waiting list group at weeks1, 4, 6, 8. Method of measurement: social phobia inventory (SPIN).;Improvement rate in symptoms of social phobia. Timepoint: The psychotherapy group at weeks 8, 15, 23 and the medication group at weeks 4, 8, 12, and the waiting list group at weeks 4, 6, 8. Method of measurement: Using the Clinical Global Impression of Improvement scale, CGI-I. | — |
Secondary
| Measure | Time frame |
|---|---|
| Global Function. Timepoint: the Psychotherapy group at weeks 1, 23 and the medication group at weeks 1, 12 and the waiting list group at weeks1, 8. Method of measurement: Using the GAF Scale to assess the global functioning. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehryar nader Mohammadi moghaddam
Tehran psychiatric institute
Outcome results
None listed